Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Barclays to hold a conference » 04:55
03/12/20
03/12
04:55
03/12/20
04:55
ABC

AmerisourceBergen

$84.90 /

-1.21 (-1.41%)

, AMAG

Amag Pharmaceuticals

$6.62 /

-0.64 (-8.82%)

, AZN

AstraZeneca

$44.57 /

-2.32 (-4.95%)

, AVNS

Avanos

$29.00 /

-3.11 (-9.69%)

, BDX

Becton Dickinson

$232.14 /

-5.18 (-2.18%)

, BIO

Bio-Rad

$345.64 /

-21.41 (-5.83%)

, CAH

Cardinal Health

$48.77 /

-0.94 (-1.89%)

, CLVS

Clovis

$6.16 /

-0.105 (-1.68%)

, COO

Cooper Companies

$323.96 /

-10.03 (-3.00%)

, CVS

CVS Health

$61.26 /

-1.36 (-2.17%)

, DGX

Quest Diagnostics

$99.75 /

-6.65 (-6.25%)

, EHTH

eHealth

$126.95 /

-6.99 (-5.22%)

, EXEL

Exelixis

$17.32 /

-1.09 (-5.92%)

, FATE

Fate Therapeutics

$23.79 /

-2.2 (-8.46%)

, FLDM

Fluidigm

$2.62 /

-0.27 (-9.34%)

, FMS

Fresenius Medical

$35.40 /

-2.24 (-5.95%)

, GRTS

Gritstone Oncology

$6.64 /

-0.39 (-5.55%)

, HRC

Hill-Rom

$89.24 /

-0.89 (-0.99%)

, HUM

Humana

$328.50 /

-20.52 (-5.88%)

, IMMU

Immunomedics

$13.38 /

-1.9 (-12.43%)

, IRWD

Ironwood

$10.49 /

-0.96 (-8.38%)

, ITGR

Integer

$79.28 /

-4.07 (-4.88%)

, JAZZ

Jazz Pharmaceuticals

$108.33 /

-4.42 (-3.92%)

, JNJ

Johnson & Johnson

$131.65 /

-10.05 (-7.09%)

, ZIOP

Ziopharm

$2.53 /

-0.24 (-8.68%)

, VNDA

Vanda Pharmaceuticals

$10.60 /

-0.2 (-1.85%)

, QGEN

Qiagen

$41.10 /

-0.33 (-0.80%)

, MRNA

Moderna

$23.61 /

+1.27 (+5.68%)

, MTD

Mettler-Toledo

$661.68 /

-35 (-5.02%)

, MTEM

Molecular Templates

$13.20 /

-1.48 (-10.08%)

, NTRA

Natera

$31.00 /

+0.07 (+0.23%)

, PODD

Insulet

$172.13 /

-8.29 (-4.59%)

, PTCT

PTC Therapeutics

$47.07 /

-4.23 (-8.25%)

Global Healthcare…

Global Healthcare Conference 2020 will be held in Miami on March 10-12.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Barclays to hold a conference » 04:55
03/11/20
03/11
04:55
03/11/20
04:55
ABC

AmerisourceBergen

$86.11 /

+2.8 (+3.36%)

, AMAG

Amag Pharmaceuticals

$7.26 /

+0.05 (+0.69%)

, AZN

AstraZeneca

$46.89 /

+1.62 (+3.58%)

, AVNS

Avanos

$32.11 /

+0.31 (+0.97%)

, BDX

Becton Dickinson

$237.32 /

+6.55 (+2.84%)

, BIO

Bio-Rad

$367.05 /

+15 (+4.26%)

, CAH

Cardinal Health

$49.71 /

+1.72 (+3.58%)

, CLVS

Clovis

$6.27 /

+0.01 (+0.16%)

, COO

Cooper Companies

$333.99 /

+16.38 (+5.16%)

, CVS

CVS Health

$62.62 /

+1.24 (+2.02%)

, DGX

Quest Diagnostics

$106.40 /

-3.43 (-3.12%)

, EHTH

eHealth

$133.94 /

+3.21 (+2.46%)

, EXEL

Exelixis

$18.41 /

+0.66 (+3.72%)

, FATE

Fate Therapeutics

$25.99 /

+1 (+4.00%)

, FLDM

Fluidigm

$2.89 /

+0.16 (+5.86%)

, FMS

Fresenius Medical

$37.64 /

+0.28 (+0.75%)

, GRTS

Gritstone Oncology

$7.03 /

+0.02 (+0.29%)

, HRC

Hill-Rom

$90.13 /

+1.34 (+1.51%)

, HUM

Humana

$349.02 /

+11.84 (+3.51%)

, IMMU

Immunomedics

$15.28 /

+0.21 (+1.39%)

, IRWD

Ironwood

$11.45 /

+0.14 (+1.24%)

, ITGR

Integer

$83.35 /

+3.1 (+3.86%)

, JAZZ

Jazz Pharmaceuticals

$112.75 /

+2.15 (+1.94%)

, JNJ

Johnson & Johnson

$141.70 /

+5.4 (+3.96%)

, ZIOP

Ziopharm

$2.77 /

-0.06 (-2.12%)

, VNDA

Vanda Pharmaceuticals

$10.80 /

+0.9 (+9.09%)

, QGEN

Qiagen

$41.43 /

+0.075 (+0.18%)

, MRNA

Moderna

$22.34 /

-1.95 (-8.03%)

, MTD

Mettler-Toledo

$696.68 /

+25.36 (+3.78%)

, MTEM

Molecular Templates

$14.68 /

-1.09 (-6.91%)

, NTRA

Natera

$30.93 /

-2.43 (-7.28%)

, PODD

Insulet

$180.42 /

+7.3 (+4.22%)

, PTCT

PTC Therapeutics

$51.35 /

+0.14 (+0.27%)

Global Healthcare…

Global Healthcare Conference 2020 will be held in Miami on March 10-12.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Barclays to hold a conference » 08:27
03/10/20
03/10
08:27
03/10/20
08:27
ABC

AmerisourceBergen

$83.31 /

-2.49 (-2.90%)

, AMAG

Amag Pharmaceuticals

$7.21 /

-0.47 (-6.12%)

, AZN

AstraZeneca

$45.27 /

-2.25 (-4.73%)

, AVNS

Avanos

$31.80 /

-0.71 (-2.18%)

, BDX

Becton Dickinson

$232.60 /

-4.81 (-2.03%)

, BIO

Bio-Rad

$352.05 /

-23.16 (-6.17%)

, CAH

Cardinal Health

$47.99 /

-3.22 (-6.29%)

, CLVS

Clovis

$6.26 /

-1.585 (-20.22%)

, COO

Cooper Companies

$317.61 /

-15.52 (-4.66%)

, CVS

CVS Health

$61.38 /

-2.76 (-4.30%)

, DGX

Quest Diagnostics

$109.83 /

-2.17 (-1.94%)

, EHTH

eHealth

$130.56 /

-3.85 (-2.86%)

, EXEL

Exelixis

$17.75 /

-0.88 (-4.72%)

, FATE

Fate Therapeutics

$24.99 /

-4.35 (-14.83%)

, FLDM

Fluidigm

$2.73 /

-0.24 (-8.08%)

, FMS

Fresenius Medical

$37.36 /

-1.82 (-4.65%)

, GRTS

Gritstone Oncology

$7.01 /

-0.84 (-10.70%)

, HRC

Hill-Rom

$88.79 /

-7.16 (-7.46%)

, HUM

Humana

$337.18 /

-29.73 (-8.10%)

, IMMU

Immunomedics

$15.07 /

-1.35 (-8.22%)

, IRWD

Ironwood

$11.31 /

-0.93 (-7.60%)

, ITGR

Integer

$80.25 /

-4.87 (-5.72%)

, JAZZ

Jazz Pharmaceuticals

$110.60 /

-9.17 (-7.66%)

, JNJ

Johnson & Johnson

$136.30 /

-5.83 (-4.10%)

, ZIOP

Ziopharm

$2.83 /

-0.435 (-13.34%)

, VNDA

Vanda Pharmaceuticals

$9.90 /

-0.62 (-5.89%)

, QGEN

Qiagen

$41.36 /

-0.225 (-0.54%)

, MRNA

Moderna

$24.29 /

-5.29 (-17.88%)

, MTD

Mettler-Toledo

$671.32 /

-43.68 (-6.11%)

, MTEM

Molecular Templates

$15.77 /

-1.6 (-9.21%)

, NTRA

Natera

$33.36 /

-4.97 (-12.97%)

, PODD

Insulet

$173.12 /

-6.39 (-3.56%)

, PTCT

PTC Therapeutics

$51.21 /

-3.8 (-6.91%)

Global Healthcare…

Global Healthcare Conference 2020 will be held in Miami on March 10-12.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
Recommendations
Fresenius Medical price target lowered to EUR 89.70 from EUR 89.95 at Berenberg » 11:52
03/05/20
03/05
11:52
03/05/20
11:52
FMS

Fresenius Medical

$39.21 /

-0.54 (-1.36%)

Berenberg analyst Tom…

Berenberg analyst Tom Jones lowered the firm's price target on Fresenius Medical to EUR 89.70 from EUR 89.95 and keeps a Buy rating on the shares. The analyst expects 2020 to be a better year for the company, and added that 2021 should be "even brighter," citing changes to Medicare Advantage eligibility rules, rising home dialysis penetration, the Cost Optimization Program, and investments made in 2019 and 2020.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Fresenius Medical management to meet with Bernstein » 04:55
02/24/20
02/24
04:55
02/24/20
04:55
FMS

Fresenius Medical

$40.98 /

-1.02 (-2.43%)

Meeting to be held in…

Meeting to be held in London, England on February 24 hosted by Bernstein.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Fresenius Medical management to meet with Bernstein » 08:44
02/20/20
02/20
08:44
02/20/20
08:44
FMS

Fresenius Medical

$40.91 /

+1.01 (+2.53%)

Meeting to be held in…

Meeting to be held in London, England on February 24 hosted by Bernstein.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Fresenius Medical boosts dividend to EUR 1.20 per share » 13:25
02/19/20
02/19
13:25
02/19/20
13:25
FMS

Fresenius Medical

$40.25 /

+0.35 (+0.88%)

The company said in its…

The company said in its earnings release, "Based on the solid results for 2019, the General Partner and the Supervisory Board will propose a new record dividend of EUR 1.20 per share, corresponding to a total payout of EUR 358 million, to the Annual General Meeting in May 2020. This proposal would result in the 23rd consecutive dividend increase. In order to create additional shareholder value, Fresenius Medical Care launched a share buy-back program in 2019. Between March and December 2019, 8.9 million own shares were bought back at a total purchase price of EUR 600 million. The Company intends to use its residual authorization of EUR 400 million over the course of 2020."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Fresenius Medical affirms mid to high single digit 2020 growth outlook » 13:24
02/19/20
02/19
13:24
02/19/20
13:24
FMS

Fresenius Medical

$40.25 /

+0.35 (+0.88%)

Fresenius Medical Care…

Fresenius Medical Care expects both revenue and net income to grow at a mid to high single digit rate in 2020. "These targets are in constant currency and exclude special items and are based on the adjusted results 2019 including the effects of the operations of the NxStage acquisition and the IFRS 16 implementation," the company added.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Fresenius Medical reports Q4 adjusted EPS EUR 1.36 vs. EUR 1.29 last year » 13:22
02/19/20
02/19
13:22
02/19/20
13:22
FMS

Fresenius Medical

$40.25 /

+0.35 (+0.88%)

Reports Q4 revenue EUR…

Reports Q4 revenue EUR 4.58B vs. EUR 4.30B last year. The company said, "2019 was a successful year for Fresenius Medical Care. We achieved our revenue and net income targets and are therefore proposing our 23rd consecutive dividend increase. Last year we also invested more strongly in our future growth, particularly in the area of home dialysis and in developing economies. In addition, our measures to increase efficiency and optimize our cost base are progressing according to plan. As a consequence, we expect growth to accelerate, and confirm the 2020 outlook that we issued early last year."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Fresenius Medical upgraded to Buy from Hold at Jefferies » 04:59
01/21/20
01/21
04:59
01/21/20
04:59
FMS

Fresenius Medical

$37.64 /

+0.125 (+0.33%)

Jefferies analyst James…

Jefferies analyst James Vane-Tempest upgraded Fresenius Medical Care to Buy from Hold with a $44.50 price target. The company's homecare strategy is being underestimated by the market and the roll out of NxStage dialysis products could drive shareholder value, Vane-Tempest tells investors in a research note. The analyst believes Fresenius Medical is among the stocks in European Healthcare that could double over the next five years.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.